Plethora Solutions Holdings Plc Strategic SWOT Analysis Review [Report Updated: 12102017] Prices from USD $125

07:35 EDT 21 Oct 2017 | BioPortfolio Reports

Plethora Solutions Holdings Plc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.

Corporate strategy GlobalData's summarization of the company's business strategy.

SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities A list of key manufacturing facilities of the company.


Plethora Solutions Holdings plc Plethora, a subsidiary of Regent Pacific is a pharmaceutical company which develops and markets products for the treatment and management of urological disorders. It focuses on the development of medicines for the treatment of urology and sexual health. The company's lead product candidate is Fortacin, a metereddose aerosol formulation of lidocaine and prilocaine. It is topical product for the treatment of premature ejaculation. The product has received marketing approval in Europe. The company has partnerships with companies such as Recordati and Pharmaserve among others. Plethora is headquartered in Chalgrove, Oxfordshire, the UK.

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Original Article: Plethora Solutions Holdings Plc Strategic SWOT Analysis Review [Report Updated: 12102017] Prices from USD $125


More From BioPortfolio on "Plethora Solutions Holdings Plc Strategic SWOT Analysis Review [Report Updated: 12102017] Prices from USD $125"

Quick Search


Relevant Topics

Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...

Sexual Health
The World Health Organization (WHO) definition of sexual health; "the state of physical, emotional, mental and social well-being related to sexuality; it is not merely the absence of disease, dysfunction and infirmity. Sexual health requires a posit...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.